Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|July 1, 1994
Cardiotoxicity of chemotherapyM de Forni, J P Armand
Fundamental & Clinical Pharmacology|January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.
Bulletin Du Cancer|December 1, 1994
[Cardiotoxicity of 5-fluorouracil: a question of formulation]L Lemaire, M Arellano, M C Malet-Martino, et al.
British Journal of Cancer|July 1, 1992
Cardiotoxicity of commercial 5-fluorouracil vials stems from the alkaline hydrolysis of this drugL Lemaire, M C Malet-Martino, M de Forni, et al.
Bulletin Du Cancer|January 1, 1990
[Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases]M de Forni, R Bugat, F Sorbette, et al.
Biochemical and Biophysical Research Communications|July 29, 1988
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiencyA Lespine, N Dousset, B Perret, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Stability of commercial solutions of 5-fluorouracil for continuous infusion in an ambulatory pumpA Fournet, V Gilard, M Malet-Martino, et al.
Bulletin Du Cancer|April 1, 1993
Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic peritoneographyM de Forni, A Boneu, P Otal, et al.
Acta Medica Austriaca|January 1, 1989
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfateP Canal, M de Forni, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinizationM de Forni, G G Chabot, J P Armand, et al.
Pageof 4